ReviewAnnals of medicine and surgery (2012)2025

The synergistic potential of camrelizumab and rivoceranib in advanced hepatocellular carcinoma: a review of current evidence.

Khadija Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.